Iain Stuart

Insider Reports History

Entity
Individual
Location
C/O Foamix Pharmaceuticals Ltd., 2 Holzman Street, Weizmann Science Park, Rehovot, Israel
Signature
/s/ Mutya Harsch, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Iain Stuart:

Stock Role Class Num Shares Value Price $ Report Date Ownership
VYNE Therapeutics Inc. CHIEF SCIENTIFIC OFFICER Common Stock 134K $257K $1.92 Jul 1, 2024 Direct
VYNE Therapeutics Inc. CHIEF SCIENTIFIC OFFICER Stock Option (right to buy) 62.5K Jan 1, 2024 Direct

Insider Reports Filed by Iain Stuart

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VYNE VYNE Therapeutics Inc. Jul 1, 2024 1 -$265 4 Jul 3, 2024 CHIEF SCIENTIFIC OFFICER
VYNE VYNE Therapeutics Inc. Apr 1, 2024 1 -$484 4 Apr 3, 2024 CHIEF SCIENTIFIC OFFICER
VYNE VYNE Therapeutics Inc. Jan 1, 2024 3 -$358 4 Jan 3, 2024 Chief Scientific Officer
VYNE VYNE Therapeutics Inc. Dec 13, 2023 2 $0 4 Dec 15, 2023 Chief Scientific Officer
VYNE VYNE Therapeutics Inc. Oct 2, 2023 1 -$4.53K 4 Oct 4, 2023 Chief Scientific Officer
VYNE VYNE Therapeutics Inc. Jun 30, 2023 1 -$619 4 Jul 5, 2023 Chief Scientific Officer
VYNE VYNE Therapeutics Inc. Mar 31, 2023 1 -$1.48K 4 Apr 4, 2023 Chief Scientific Officer
VYNE VYNE Therapeutics Inc. Dec 31, 2022 1 -$258 4 Jan 4, 2023 Chief Scientific Officer
VYNE VYNE Therapeutics Inc. Sep 30, 2022 1 -$383 4 Oct 4, 2022 Chief Scientific Officer
VYNE VYNE Therapeutics Inc. Jun 30, 2022 1 -$669 4 Jul 5, 2022 Chief Scientific Officer
VYNE VYNE Therapeutics Inc. Mar 31, 2022 1 -$2.25K 4 Apr 4, 2022 Chief Scientific Officer
VYNE VYNE Therapeutics Inc. Mar 17, 2022 2 $0 4 Mar 18, 2022 Chief Scientific Officer
VYNE VYNE Therapeutics Inc. Dec 31, 2021 1 -$1.28K 4 Jan 4, 2022 Chief Scientific Officer
VYNE VYNE Therapeutics Inc. Sep 30, 2021 1 -$2.06K 4 Oct 1, 2021 Chief Scientific Officer
VYNE VYNE Therapeutics Inc. Sep 2, 2021 2 $0 4 Sep 3, 2021 Chief Scientific Officer
VYNE VYNE Therapeutics Inc. Jun 30, 2021 1 -$10.8K 4 Jul 2, 2021 Chief Scientific Officer